Alogliptin Impurity 35 | CAS 872414-52-3 - Request Quote
Alogliptin Impurity 35
| SZ CAT No: | SZ-A053043 |
| CAS No | 872414-52-3 |
| Mol.F. | C8H8BrNO |
| Mol.Wt. | 214.1 |
| Inv. Status | Synthesis on demand |
| Shipping Condition | Room Temperature |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Alogliptin Impurity 35 is chemically 2-(Bromomethyl)Benzamide. Alogliptin Impurity 35 is supplied with detailed characterization data compliant with regulatory guideline. Alogliptin Impurity 35 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Alogliptin.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 872414-52-3
Purchase 872414-52-3
Order 872414-52-3
Enquire 872414-52-3
price of 872414-52-3
872414-52-3 Supplier
872414-52-3 Manufacturer
872414-52-3 Exporter
buy high quality Alogliptin Impurity 35
Purchase Alogliptin Impurity 35
Alogliptin Impurity 35 suppliers
Alogliptin Impurity 35 manufacturers
Alogliptin Impurity 35 price
Order Alogliptin Impurity 35
Enquire Alogliptin Impurity 35
Alogliptin Impurity 35 cost
Alogliptin Impurity 35 Supplier
Alogliptin Impurity 35 Distributor
Alogliptin Impurity 35 for Method Validation
Alogliptin Reference Standard
Alogliptin Impurity 35 for ANDA Filing
Alogliptin Impurity 35 for Forced Degradation Studies
Alogliptin Impurity 35 Identification Standards
Alogliptin Impurity 35 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.